Long-term cost-effectiveness of Clopidogrel® in patients with acute coronary syndrome without ST-segment elevation in Germany

被引:1
|
作者
Brüggenjürgen, B
Ehlken, B
机构
[1] Alpha Care GmbH, Celle, Germany
[2] MERG, Munich, Germany
关键词
D O I
10.1016/S1098-3015(10)65787-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:686 / 686
页数:1
相关论文
共 50 条
  • [1] Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany
    B. Brüggenjürgen
    P. Lindgren
    B. Ehlken
    H.-J. Rupprecht
    S. N. Willich
    The European Journal of Health Economics, 2007, 8 : 51 - 57
  • [2] Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany
    Brueggenjuergen, B.
    Lindgren, P.
    Ehlken, B.
    Rupprecht, H. -J.
    Willich, S. N.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2007, 8 (01): : 51 - 57
  • [3] Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
    Weintraub, WS
    Mahoney, EM
    Lamy, A
    Culler, S
    Yuan, Y
    Caro, J
    Gabriel, S
    Yusuf, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) : 838 - 845
  • [4] The cost-effectiveness of clopidogrel in acute coronary syndromes without st-segment elevation in Poland
    Pietrasik, A
    Niewada, M
    Spiesser, J
    Gabriel, S
    VALUE IN HEALTH, 2004, 7 (06) : 687 - 687
  • [5] Cost-Effectiveness of Fondaparinux in Patients with Acute Coronary Syndrome without ST-Segment Elevation
    Pepe, Camila
    Machado, Marcio
    Olimpio, Alexandre
    Ramos, Rui
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 99 (01) : 613 - 622
  • [6] Cost-effectiveness analysis of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in Hungary
    Borsos, K
    Nagy, B
    Spiesser, J
    Gabriel, S
    Blaskó, G
    VALUE IN HEALTH, 2005, 8 (06) : A88 - A88
  • [7] Cost-effectiveness analysis of clopidogrel in acute coronary syndromes without ST-segment elevation in the Netherlands
    van Hout, BA
    Tangelder, MJD
    Bervoets, P
    Gabriel, S
    VALUE IN HEALTH, 2003, 6 (06) : 667 - 668
  • [8] Modeling the cost-effectiveness of clopidogrel in acute coronary syndromes without ST-segment elevation in Sweden
    Lindgren, P
    Jonsson, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 540A - 540A
  • [9] Short and long term cost-effectiveness analysis of clopidogrel in patients with acute coronary syndrome without ST segment elevation (ACS) in Scandinavian countries
    Lindgren, P
    Jönsson, B
    Spiesser, J
    Carita, P
    Gabriel, S
    VALUE IN HEALTH, 2003, 6 (06) : 621 - 621
  • [10] Cost-effectiveness of clopidogrel in patients with ST-segment elevation myocardial infarction
    Zhang, Zefeng
    Kolm, Paul
    Spiesser, Julie
    Jackson, Joseph
    Gabriel, Sylvie
    Zhao, Liping
    Weintraub, William
    CIRCULATION, 2006, 114 (18) : 827 - 827